LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.03 | 17.25 | 3110 | 5367 | 0.5795 | 0.8725 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.03 | 17.25 | 4470 | 5367 | 0.8329 | 0.9563 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.00 | 17.25 | 3821 | 5546 | 0.6889 | 0.9125 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.00 | 17.25 | 4460 | 5546 | 0.8041 | 0.9483 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.00 | 17.25 | 2686 | 5546 | 0.4842 | 0.8332 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.00 | 17.25 | 4684 | 5546 | 0.8444 | 0.9598 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.97 | 17.25 | 3570 | 5618 | 0.6354 | 0.8942 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.97 | 17.25 | 4637 | 5618 | 0.8253 | 0.9545 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.97 | 17.25 | 2685 | 5618 | 0.4779 | 0.8307 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.97 | 17.25 | 4916 | 5618 | 0.8749 | 0.9682 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.94 | 17.25 | 3340 | 5681 | 0.5879 | 0.8769 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.94 | 17.25 | 4820 | 5681 | 0.8484 | 0.9611 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.94 | 17.25 | 2648 | 5681 | 0.4661 | 0.8255 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.94 | 17.25 | 5105 | 5681 | 0.8985 | 0.9746 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.91 | 17.25 | 3314 | 5730 | 0.5783 | 0.8734 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.91 | 17.25 | 5024 | 5730 | 0.8767 | 0.9688 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.91 | 17.25 | 2387 | 5730 | 0.4165 | 0.8014 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.91 | 17.25 | 5293 | 5730 | 0.9236 | 0.9811 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.88 | 17.25 | 3444 | 5826 | 0.5911 | 0.8787 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.88 | 17.25 | 5209 | 5826 | 0.8941 | 0.9735 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.88 | 17.25 | 2103 | 5826 | 0.3610 | 0.7715 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.88 | 17.25 | 5417 | 5826 | 0.9298 | 0.9827 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.85 | 17.25 | 3108 | 5861 | 0.5302 | 0.8546 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.85 | 17.25 | 5331 | 5861 | 0.9095 | 0.9776 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.85 | 17.25 | 1560 | 5861 | 0.2661 | 0.7087 | MN20160310_N02 | L09 |